display

In Berlin, for the time being, people under the age of 60 are no longer vaccinated against the coronavirus with the Astrazeneca vaccine.

The Berlin Health Senator Dilek Kalayci (SPD) announced on Tuesday in Berlin that the vaccinations for this group would be suspended.

She justified this with further cases of side effects associated with the vaccination.

Kalayci said she wanted to wait and see how the vaccination commission's new recommendation was.

In addition, she wants to exchange ideas with the Federal Ministry of Health about how to deal with the second vaccination of this age group who have already received a first dose of Astrazeneca.

The Charité and Vivantes clinics in the capital also stopped vaccinations until further notice with reference to cases of cerebral vein thrombosis in Germany.

In the clinics, the suspension of vaccinations applies to women under 55 years of age.

This mainly applies to our own workforce.

The Charité spokeswoman, Manuela Zingl, said on Tuesday: "From the Charité's point of view, this step is necessary because further cerebral vein thromboses in women in Germany have become known in the meantime."

display

In North Rhine-Westphalia, the heads of five of the six university clinics also spoke out in favor of a temporary stop to vaccinations of younger women with Astrazeneca.

The risk of further deaths is too high, according to a joint letter to the federal and state health ministers, which is available to the German press agency.

The Berlin Charité spokeswoman Zingl emphasized that there were no complications in the Charité after vaccinations with Astrazeneca.

However, this wants to act as a precaution and wait for final evaluations.

During the pandemic, the Charité has given around 16,000 first and second vaccinations to its staff.

“Astrazeneca accounted for the largest part of this,” said Zingl.

Germany - and numerous other countries - had temporarily suspended vaccination with the Astrazeneca substance in March because several cases of thrombosis (blood clots) in the cerebral veins were reported in relation to the vaccination.

The vaccine is now being given again.

The European Medicines Agency Ema had confirmed the safety of the vaccine, and the Standing Vaccination Commission in Germany had spoken out in favor of further use of the product.

display

The district of Euskirchen in North Rhine-Westphalia had already temporarily stopped the corona vaccination of women under 55 with the active ingredient from Astrazeneca on Monday.

After a vaccinated woman (47) died last week, the district has now been reported to be suspected of having “a serious illness” in a 28-year-old after being vaccinated with Astrazeneca.

Both had suffered a sinus vein thrombosis, according to the district.

In Germany, 31 cases of sinus vein thrombosis after vaccination with the Astrazeneca vaccine are known, as the Paul Ehrlich Institute reported on Tuesday.

By noon on Monday (March 29), 31 cases had been reported to the institute, and thrombocytopenia was also reported in 19 cases.

In nine cases, the outcome was fatal, as the institute responsible for vaccine safety in Langen reported.

With the exception of two cases, according to the PEI, all reports concerned women aged 20 to 63 years.

The two men were 36 and 57 years old.

According to the Robert Koch Institute's vaccination rate monitoring, 2.7 million first doses and 767 second doses of Astrazeneca were vaccinated up to and including Monday.

display

31 cases of sinus vein thrombosis after vaccination with AstraZeneca have now been reported to the Paul Ehrlich Institute.

The institute announced this at the request of “Spiegel”.

In 19 cases, a lack of blood platelets, a thrombocytopenia, was reported.

Those affected died in nine cases.

It is noticeable that men were only affected in two cases, a 36-year-old and a 57-year-old.

According to the PEI, all other reports concern women aged 20 to 63 years.

According to the Robert Koch Institute, around 2.7 million people in Germany have been vaccinated with Vaxzevria.

According to vaccination monitoring data from eight federal states, women under the age of 70 make up two thirds of those vaccinated so far.

Note: In an earlier version we wrote that Berlin had only stopped vaccinations for women under 60.

We apologize for any inconvenience.